Publications for Liang Qiao
2020
Pan, Z., Cai, J., Lin, J., Zhou, H., Peng, J., Liang, J., Xia, L.,
Yin, Q., Zou, B., Zheng, J., Qiao, L., et al (2020). A novel
protein encoded by circFNDC3B inhibits tumor progression and
EMT through regulating Snail in colon cancer. Molecular
Cancer, 19(1). <a href="http://dx.doi.org/10.1186/s12943-020-
01179-5">[More Information]</a>
Dewdney, B., Roberts, A., Qiao, L., George, J., Hebbard, L.
(2020). A Sweet Connection? Fructose's Role in Hepatocellular
Carcinoma. Biomolecules, 10(4), 496. <a
href="http://dx.doi.org/10.3390/biom10040496">[More
Information]</a>
Liu, S., Guo, R., Hou, X., Zhang, Y., Jiang, X., Wang, T., Wu,
X., Xu, K., Pan, X., Qiao, L. (2020). Adipose-tissue derived
porcine mesenchymal stem cells efficiently ameliorate
CCl<inf>4</inf>-induced acute liver failure in mice.
Cytotechnology, 72(3), 327-341. <a
href="http://dx.doi.org/10.1007/s10616-020-00370-2">[More
Information]</a>
Sun, W., Shi, Q., Zhang, H., Yang, K., Ke, Y., Wang, Y., Qiao,
L. (2020). Advances in the techniques and methodologies of
cancer gene therapy. Discovery Medicine, 27(146), 45-55.
Nguyen, R., Bae, D., Zhou, G., Read, S., Ahlenstiel, G.,
George, J., Qiao, L. (2020). Application of organoids in
translational research of human diseases with a particular focus
on gastrointestinal cancers. Biochimica Et Biophysica Acta-
Reviews On Cancer, 1873 (2), 1-12. <a
href="http://dx.doi.org/10.1016/j.bbcan.2020.188350">[More
Information]</a>
Ding, W., Wu, W., Chen, Y., Chen, H., Fan, J., Qiao, L. (2020).
Expression of Notch family is altered in non-alcoholic fatty
liver disease. Molecular Medicine Reports, 22(3), 1702-1708.
<a href="http://dx.doi.org/10.3892/mmr.2020.11249">[More
Information]</a>
Fu, W., Gao, L., Huang, C., Yao, J., Lin, Y., Bai, B., Yue, P.,
Liu, Y., Meng, W., Qiao, L., et al (2020). Mechanisms and
importance of histone modification enzymes in targeted therapy
for hepatobiliary cancers. Discovery Medicine, 28(151), 17-28.
Liang, Y., Liang, Q., Qiao, L., Xiao, F. (2020). MicroRNAs
Modulate Drug Resistance-Related Mechanisms in
Hepatocellular Carcinoma. Frontiers in Oncology, 10. <a
href="http://dx.doi.org/10.3389/fonc.2020.00920">[More
Information]</a>
Shek, D., Read, S., Akhuba, L., Qiao, L., Gao, B., Nagrial, A.,
Carlino, M., Ahlenstiel, G. (2020). Non-coding RNA and
immune-checkpoint inhibitors: Friends or foes?
Immunotherapy, 12(7), 513-529. <a
href="http://dx.doi.org/10.2217/imt-2019-0204">[More
Information]</a>
Zhang, J., Su, G., Lin, Y., Meng, W., Lai, J., Qiao, L., Li, X.,
Xie, X. (2020). Targeting cyclin-dependent kinases in
gastrointestinal cancer therapy. Discovery Medicine, 27(146),
27-36.
2019
Metwally, M., Bayoumi, A., Romero-Gomez, M., Thabet, K.,
John, M., Adams, L., Huo, X., Aller, R., Garcia-Monzon, C.,
Arias-Loste, M., Liddle, C., Qiao, L., George, J., Eslam, M., et
al (2019). A polymorphism in the Irisin-encoding gene
(FNDC5) associates with hepatic steatosis by differential
miRNA binding to the 3 ' UTR. Journal of Hepatology, 70(3),
494-500. <a
href="http://dx.doi.org/10.1016/j.jhep.2018.10.021">[More
Information]</a>
El Sharkawy, R., Bayoumi, A., Metwally, M., Mangia, A.,
Berg, T., Romero-Gomez, M., Abate, M., Irving, W., Sheridan,
D., Dore, G., Latchoumanin, O., Thabet, K., Najim, M.,
Douglas, M., Liddle, C., Qiao, L., George, J., Eslam, M., et al
(2019). A variant in the MICA gene is associated with liver
fibrosis progression in chronic hepatitis C through TGF-β1
dependent mechanisms. Scientific Reports, 9(1), 1-10. <a
href="http://dx.doi.org/10.1038/s41598-018-35736-2">[More
Information]</a>
Zhang, L., Chen, J., Yong, J., Qiao, L., Xu, L., Liu, C. (2019).
An essential role of RNF187 in Notch1 mediated metastasis of
hepatocellular carcinoma. Journal of Experimental and Clinical
Cancer Research, 38(1), 1-15. <a
href="http://dx.doi.org/10.1186/s13046-019-1382-x">[More
Information]</a>
Pu, K., Wang, Y., Bai, S., Wei, H., Zhou, Y., Fan, J., Qiao, L.
(2019). Diagnostic accuracy of controlled attenuation parameter
(CAP) as a non-invasive test for steatosis in suspected non-
alcoholic fatty liver disease: a systematic review and meta-
analysis. BMC Gastroenterology, 19(1). <a
href="http://dx.doi.org/10.1186/s12876-019-0961-9">[More
Information]</a>
Xu, K., Zhao, X., Fu, X., Xu, K., Li, Z., Miao, L., Li, Y., Cai,
Z., Qiao, L., Bao, J. (2019). Gender effect of hyperuricemia on
the development of nonalcoholic fatty liver disease (NAFLD):
A clinical analysis and mechanistic study. Biomedicine and
Pharmacotherapy, 117, 1-7. <a
href="http://dx.doi.org/10.1016/j.biopha.2019.109158">[More
Information]</a>
Xu, M., Xu, H., Lin, Y., Sun, X., Wang, L., Fang, Z., Su, X.,
Liang, X., Hu, Y., Liu, Z., Qiao, L., et al (2019). LECT2, a
Ligand for Tie1, Plays a Crucial Role in Liver Fibrogenesis.
Cell, 178(6), 1478-1492.e20. <a
href="http://dx.doi.org/10.1016/j.cell.2019.07.021">[More
Information]</a>
John, M., Kim, K., Bae, S., Qiao, L., George, J. (2019). Role of
BMP-9 in human liver disease. Gut, 68(11), 2097-2100. <a
href="http://dx.doi.org/10.1136/gutjnl-2018-317543">[More
Information]</a>
Zhao, Z., Lai, J., Qiao, L., Fan, J. (2019). Role of gut microbial
metabolites in nonalcoholic fatty liver disease. Journal of
Digestive Diseases, 20(4), 181-188. <a
href="http://dx.doi.org/10.1111/1751-2980.12709">[More
Information]</a>
Walker, S., Wankell, M., Ho, V., White, R., Deo, N., Devine,
C., Dewdney, B., Bhathal, P., Govaere, O., Roskams, T., Qiao,
L., George, J., Hebbard, L. (2019). Targeting mTOR and Src
restricts hepatocellular carcinoma growth in a novel murine
liver cancer model. PloS One, 14(2), 1-16. <a
href="http://dx.doi.org/10.1371/journal.pone.0212860">[More
Information]</a>
Yang, R., Pan, Q., Liu, X., Zhou, D., Xin, F., Zhao, Z., Zhang,
R., Zeng, J., Qiao, L., Hu, C., et al (2019). Therapeutic effect
and autophagy regulation of myriocin in nonalcoholic
steatohepatitis. Lipids in Health and Disease, 18(1), 1-11. <a
href="http://dx.doi.org/10.1186/s12944-019-1118-0">[More
Information]</a>
Xu, K., Liu, S., Zhao, X., Zhang, X., Fu, X., Zhou, Y., Xu, K.,
Miao, L., Li, Z., Li, Y., Qiao, L., et al (2019). Treating
hyperuricemia related non-alcoholic fatty liver disease in rats
with resveratrol. Biomedicine and Pharmacotherapy, 110, 844-
849. <a
href="http://dx.doi.org/10.1016/j.biopha.2018.12.039">[More
Information]</a>
2018
Zhou, G., Latchoumanin, O., Hebbard, L., Duan, W., Liddle,
C., George, J., Qiao, L. (2018). Aptamers as targeting ligands
and therapeutic molecules for overcoming drug resistance in
cancers. Advanced Drug Delivery Reviews, 134, 107-121. <a
href="http://dx.doi.org/10.1016/j.addr.2018.04.005">[More
Information]</a>
Zhang, J., Su, G., Tang, Z., Wang, L., Fu, W., Zhao, S., Ba, Y.,
Bai, B., Yue, P., Lin, Y., Qiao, L., et al (2018). Curcumol exerts
anticancer effect in cholangiocarcinoma cells via down-
regulating CDKL3. Frontiers in Physiology, 9(MAR). <a
href="http://dx.doi.org/10.3389/fphys.2018.00234">[More
Information]</a>
Wu, T., Wang, C., Wang, W., Hui, Y., Zhang, R., Qiao, L., Dai,
Y. (2018). Embelin impairs the accumulation and activation of
MDSCs in colitis-associated tumorigenesis. OncoImmunology,
7(11), e1498437-1-e1498437-11. <a
href="http://dx.doi.org/10.1080/2162402X.2018.1498437">[Mo
re Information]</a>
Pu, C., Huang, H., Wang, Z., Zou, W., Lv, Y., Zhou, Z., Zhang,
Q., Qiao, L., Wu, F., Shao, S. (2018). Extracellular vesicle-
associated mir-21 and mir-144 are markedly elevated in serum
of patients with hepatocellular carcinoma. Frontiers in
Physiology, 9, 1-8. <a
href="http://dx.doi.org/10.3389/fphys.2018.00930">[More
Information]</a>
Yuan, H., Chen, Z., Bai, S., Wei, H., Wang, Y., Ji, R., Guo, Q.,
Li, Q., Ye, Y., Wu, J., Qiao, L., et al (2018). Molecular
mechanisms of lncRNA SMARCC2/miR-551b-3p/TMPRSS4
axis in gastric cancer. Cancer Letters, 418, 84-96. <a
href="http://dx.doi.org/10.1016/j.canlet.2018.01.032">[More
Information]</a>
Alzahrani, B., Iseli, T., Ramezani-Moghadam, M., Ho, V.,
Wankell, M., Sun, E., Qiao, L., George, J., Hebbard, L. (2018).
The role of AdipoR1 and AdipoR2 in liver fibrosis. Biochimica
et Biophysica Acta - Molecular Basis of Disease, 1864 (3), 700-
708. <a
href="http://dx.doi.org/10.1016/j.bbadis.2017.12.012">[More
Information]</a>
2017
Obeid, S., Wankell, M., Charrez, B., Sternberg, J., Kreuter, R.,
Esmaili, S., Ramezani-Moghadam, M., Devine, C., Read, S.,
Bhathal, P., Ahlenstiel, G., Qiao, L., George, J., Hebbard, L., et
al (2017). Adiponectin confers protection from acute colitis and
restricts a B cell immune response. Journal of Biological
Chemistry, 292(16), 6569-6582. <a
href="http://dx.doi.org/10.1074/jbc.M115.712646">[More
Information]</a>
Peng, M., Zhang, Q., Cheng, Y., Fu, S., Yang, H., Gou, X.,
Zhang, J., Wang, L., Zhang, L., Xue, Z., Qiao, L., et al (2017).
Apolipoprotein A-I mimetic peptide 4F suppresses tumor-
associated macrophages and pancreatic cancer progression.
Oncotarget, 8(59), 99693-99706. <a
href="http://dx.doi.org/10.18632/oncotarget.21157">[More
Information]</a>
Zhou, G., Latchoumanin, O., Bagdesar, M., Hebbard, L., Duan,
W., Liddle, C., George, J., Qiao, L. (2017). Aptamer-based
therapeutic approaches to target cancer stem cells. Theranostics,
7(16), 3948-3961. <a
href="http://dx.doi.org/10.7150/thno.20725">[More
Information]</a>
Huo, X., Han, S., Wu, G., Latchoumanin, O., Zhou, G., Qiao,
L., George, J., Hebbard, L. (2017). Dysregulated long
noncoding RNAs (lncRNAs) in hepatocellular carcinoma:
Implications for tumorigenesis, disease progression, and liver
cancer stem cells. Molecular Cancer, 16(1), 1-10. <a
href="http://dx.doi.org/10.1186/s12943-017-0734-4">[More
Information]</a>
Yan, S., Fan, J., Qiao, L. (2017). Hepatitis B virus (HBV)
infection and hepatocellular carcinoma- New insights for an old
topic. Current Cancer Drug Targets, 17(6), 505-511. <a
href="http://dx.doi.org/10.2174/1568009616666160926124530"
>[More Information]</a>
Li, J., Zhou, Z., Zhang, X., Zheng, L., He, D., Ye, Y., Zhang,
Q., Qi, C., He, X., Yu, C., Qiao, L., et al (2017). Inflammatory
molecule, PSGL-1, deficiency activates macrophages to
promote colorectal cancer growth through NFKB signaling.
Molecular Cancer Research, 15(4), 467-477. <a
href="http://dx.doi.org/10.1158/1541-7786.MCR-16-
0309">[More Information]</a>
Cai, Z., Xu, K., Li, Y., Lv, Y., Bao, J., Qiao, L. (2017). Long
noncoding RNA in liver cancer stem cells. Discovery Medicine,
24(131), 87-93.
Bao, J., Qiao, L. (2017). New developments on targeted cancer
therapy: Multi-faceted issues in targeted cancer therapy. Cancer
Letters, 387, 1-2. <a
href="http://dx.doi.org/10.1016/j.canlet.2016.12.016">[More
Information]</a>
Wu, G., Wilson, G., George, J., Liddle, C., Hebbard, L., Qiao,
L. (2017). Overcoming treatment resistance in cancer: Current
understanding and tactics. Cancer Letters, 387, 69-76. <a
href="http://dx.doi.org/10.1016/j.canlet.2016.04.018">[More
Information]</a>
Han, S., Latchoumanin, O., Wu, G., Zhou, G., Hebbard, L.,
George, J., Qiao, L. (2017). Recent clinical trials utilizing
chimeric antigen receptor T cells therapies against solid tumors.
Cancer Letters, 390, 188-200. <a
href="http://dx.doi.org/10.1016/j.canlet.2016.12.037">[More
Information]</a>
Kong, L., Lu, Y., Zhang, S., Nan, Y., Qiao, L. (2017). Role of
nutrition, gene polymorphism, and gut microbiota in non-
alcoholic fatty liver disease. Discovery Medicine, 24(131), 95-
106.
Fu, N., Yao, H., Nan, Y., Qiao, L. (2017). Role of oxidative
stress in Hepatitis C Virus induced hepatocellular carcinoma.
Current Cancer Drug Targets, 17(6), 498-504. <a
href="http://dx.doi.org/10.2174/1568009616666160926124043"
>[More Information]</a>
Huang, B., Yang, H., Cheng, X., Wang, D., Fu, S., Shen, W.,
Zhang, Q., Zhang, L., Xue, Z., Qiao, L., et al (2017). TRF/miR-
1280 suppresses stem cell-like cells and metastasis in colorectal
cancer. Cancer Research, 77(12), 3194-3206. <a
href="http://dx.doi.org/10.1158/0008-5472.CAN-16-
3146">[More Information]</a>
2016
Liu, X., Yang, Z., Latchoumanin, O., Qiao, L. (2016).
Antagonizing programmed death-1 and programmed death
ligand-1 as a therapeutic approach for gastric cancer.
Therapeutic Advances in Gastroenterology, 9(6), 853-860. <a
href="http://dx.doi.org/10.1177/1756283X16658251">[More
Information]</a>
Zhou, G., Wilson, G., Hebbard, L., Duan, W., Liddle, C.,
George, J., Qiao, L. (2016). Aptamers: A promising chemical
antibody for cancer therapy. Oncotarget, 7(12), 13446-13463.
<a href="http://dx.doi.org/10.18632/oncotarget.7178">[More
Information]</a>
Lu, H., Wang, J., Wang, Y., Qiao, L., Zhou, Y. (2016). Embelin
and its role in chronic diseases. In Subash Chandra Gupta,
Sahdeo Prasad, Bharat B. Aggarwal (Eds.), Anti-inflammatory
Nutraceuticals and Chronic Diseases, (pp. 397-418).
Switzerland: Springer. <a href="http://dx.doi.org/10.1007/978-
3-319-41334-1_16">[More Information]</a>
Charrez, B., Qiao, L., Hebbard, L. (2016). Hepatocellular
carcinoma and non-alcoholic steatohepatitis: The state of play.
World Journal of Gastroenterology, 22(8), 2494-2502. <a
href="http://dx.doi.org/10.3748/wjg.v22.i8.2494">[More
Information]</a>
Meng, P., Zhao, S., Niu, X., Fu, N., Su, S., Wang, R., Zhang,
Y., Qiao, L., Nan, Y. (2016). Involvement of the interleukin-
23/interleukin-17 axis in chronic hepatitis C virus infection and
its treatment responses. International Journal of Molecular
Sciences, 17(7), 1-15. <a
href="http://dx.doi.org/10.3390/ijms17071070">[More
Information]</a>
Wu, T., Dai, Y., Wang, W., Teng, G., Jiao, H., Shuai, X.,
Zhang, R., Zhao, P., Qiao, L. (2016). Macrophage targeting
contributes to the inhibitory effects of embelin on colitis-
associated cancer. Oncotarget, 7(15), 19548-19558. <a
href="http://dx.doi.org/10.18632/oncotarget.6969">[More
Information]</a>
Huang, B., Cheng, X., Wang, H., Huang, W., Ga Hu, Z., Wang,
D., Zhang, K., Zhang, H., Xue, Z., Qiao, L., et al (2016).
Mesenchymal stem cells and their secreted molecules
predominantly ameliorate fulminant hepatic failure and chronic
liver fibrosis in mice respectively. Journal of Translational
Medicine, 14(1), 1-12. <a
href="http://dx.doi.org/10.1186/s12967-016-0792-1">[More
Information]</a>
Liu, J., Pu, C., Lang, L., Qiao, L., Abdullahi, M., Jiang, C.
(2016). Molecular pathogenesis of hereditary hemochromatosis.
Histology and histopathology, 31(8), 833-840. <a
href="http://dx.doi.org/10.14670/HH-11-762">[More
Information]</a>
Wang, H., Zhang, H., Zhang, Y., Wang, D., Cheng, X., Yang,
F., Zhang, Q., Xue, Z., Li, Y., Qiao, L., et al (2016). Plumbagin
protects liver against fulminant hepatic failure and chronic liver
fibrosis via inhibiting inflammation and collagen production.
Oncotarget, 7(50), 82864-82875. <a
href="http://dx.doi.org/10.18632/oncotarget.12655">[More
Information]</a>
Li, Y., Qiao, L. (2016). Role of cancer stem cells in common
gastrointestinal cancers: From pathogenesis to therapeutic
targets. Current Stem Cell Research & Therapy, 11(5), 426-
426. <a
href="http://dx.doi.org/10.2174/1574888X1105160510000736"
>[More Information]</a>
Fu, N., Niu, X., Wang, Y., Du, H., Wang, B., Du, J., Li, Y.,
Wang, R., Zhang, Y., Qiao, L., et al (2016). Role of LncRNA-
activated by transforming growth factor beta in the progression
of hepatitis C virus-related liver fibrosis. Discovery Medicine,
22(119), 29-42.
Meng, W., Li, Y., Bai, B., Bai, Z., Yue, P., Li, X., Qiao, L.
(2016). The immunosuppression role of alpha-fetoprotein in
human hepatocellular carcinoma. Discovery Medicine, 21(118),
489-494.
2015
Chang, J., Lan, T., Li, C., Ji, X., Zheng, L., Gou, H., Ou, Y.,
Wu, T., Qi, C., Qiao, L., et al (2015). Activation of Slit2-Robo1
signaling promotes liver fibrosis. Journal of Hepatology, 63(6),
1413-1420. <a
href="http://dx.doi.org/10.1016/j.jhep.2015.07.033">[More
Information]</a>
Ramezani-Moghadam, M., Wang, J., Ho, V., Iseli, T.,
Alzahrani, B., Xu, A., van der Poorten, D., Qiao, L., George, J.,
Hebbard, L. (2015). Adiponectin Reduces Hepatic Stellate Cell
Migration by Promoting Tissue Inhibitor of Metalloproteinase-1
(TIMP-1) Secretion. Journal of Biological Chemistry, 290(9),
5533-5542. <a
href="http://dx.doi.org/10.1074/jbc.M114.598011">[More
Information]</a>
Xiang, D., Shigdar, S., Qiao, G., Zhou, S., Li, Y., Wei, M.,
Qiao, L., Al Shamaileh, H., Zhu, Y., Zheng, C., et al (2015).
Aptamer-mediated cancer gene therapy. Current Gene Therapy:
the international journal for in-depth reviews on gene therapy,
15(2), 109-119. <a
href="http://dx.doi.org/10.2174/1566523214666141224095105"
>[More Information]</a>
Wang, Z., Zhou, W., Zhang, H., Qiao, L. (2015). Combination
of Anti-Angiogenesis Agents and Transarterial Embolization: Is
it a Promising Approach for the Treatment of Liver Cancer?
Discovery Medicine, 20(108), 51-55.
Wilson, G., Hebbard, L., Duan, W., Qiao, L., George, J. (2015).
Editorial: Gene therapy for gastrointestinal and liver cancers:
past experience, current status and future perspectives. Current
Gene Therapy, 15(2), 93-96. <a
href="http://dx.doi.org/10.2174/156652321502150309094913">
[More Information]</a>
Wilson, G., Hebbard, L., Duan, W., George, J., Qiao, L. (2015).
Editorial: Induced Pluripotent Stem Cells (iPSCs) in the
Gastroenterology and Hepatology: from Basic Research to
Clinical Applications. Current Stem Cell Research & Therapy,
10(3), 190-192.
Liu, X., Yang, Z., Chen, Z., Chen, R., Zhao, D., Zhou, Y., Qiao,
L. (2015). Effects of the suppression of lactate dehydrogenase
A on the growth and invasion of human gastric cancer cells.
Oncology Reports, 33(1), 157-162. <a
href="http://dx.doi.org/10.3892/or.2014.3600">[More
Information]</a>
Cheng, L., Zhang, Y., Nan, Y., Qiao, L. (2015). Induced
Pluripotent Stem Cells (iPSCs) in the Modeling of Hepatitis C
Virus Infection. Current Stem Cell Research & Therapy, 10(3),
216-219. <a
href="http://dx.doi.org/10.2174/1574888X09666140923121234
">[More Information]</a>
Wu, G., Wilson, G., George, J., Qiao, L. (2015). Modulation of
Notch Signaling as a Therapeutic Approach for Liver Cancer.
Current Gene Therapy, 15(2), 171-181. <a
href="http://dx.doi.org/10.2174/1566523214666141224100319"
>[More Information]</a>
Wu, G., Wilson, G., Zhou, G., Hebbard, L., George, J., Qiao, L.
(2015). Oct4 is a reliable marker of liver tumor propagating
cells in hepatocellular carcinoma. Discovery Medicine, 20(110),
219-229.
Sun, C., Wilson, G., Fan, J., Qiao, L. (2015). Potential
Applications of Induced Pluripotent Stem Cells (iPSCs) in
Hepatology Research. Current Stem Cell Research & Therapy,
10(3), 208-215. <a
href="http://dx.doi.org/10.2174/1574888X10666150120105946
">[More Information]</a>
Liu, S., Zhang, D., Chen, Y., Wang, B., Qiao, L. (2015).
Potential Applications of Induced Pluripotent Stem Cells
(iPSCs) in the Modeling of Gastrointestinal Disorders. Current
Stem Cell Research & Therapy, 10(3), 220-227. <a
href="http://dx.doi.org/10.2174/1574888x10666150227130122"
>[More Information]</a>
Sun, C., Fan, J., Qiao, L. (2015). Potential Epigenetic
Mechanism in Non-Alcoholic Fatty Liver Disease.
International Journal of Molecular Sciences, 16(3), 5161-5179.
<a href="http://dx.doi.org/10.3390/ijms16035161">[More
Information]</a>
Gao, J., Qiao, L., Wang, B. (2015). Primary Biliary Cirrhosis Is
a Generalized Autoimmune Epithelitis. International Journal of
Molecular Sciences, 16(3), 6432-6446. <a
href="http://dx.doi.org/10.3390/ijms16036432">[More
Information]</a>
Zhang, L., Li, Y., Qiao, L., Zhao, Y., Wei, Y., Li, Y. (2015).
Protective effects of hepatic stellate cells against cisplatin-
induced apoptosis in human hepatoma G2 cells. International
Journal of Oncology, 47(2), 632-640. <a
href="http://dx.doi.org/10.3892/ijo.2015.3024">[More
Information]</a>
Meng, W., Bai, B., Sheng, L., Li, Y., Yue, P., Li, X., Qiao, L.
(2015). Role of helicobacter pylori in gastric cancer: Advances
and controversies. Discovery Medicine, 20(111), 285-293.
Zhang, L., Song, X., Mohri, Y., Qiao, L. (2015). Role of
Inflammation and Tumor Microenvironment in the
Development of Gastrointestinal Cancers: What Induced
Pluripotent Stem Cells Can Do? Current Stem Cell Research &
Therapy, 10(3), 245-250. <a
href="http://dx.doi.org/10.2174/1574888X09666140812112305
">[More Information]</a>
Zhang, Q., Zhou, D., Lei, Y., Zheng, L., Chen, S., Gou, H., Gu,
Q., He, X., Lan, T., Qi, C., Qiao, L., et al (2015). Slit2/Robo1
signaling promotes intestinal tumorigenesis through Src-
mediated activation of the Wnt/β-catenin pathway. Oncotarget,
6(5), 3123-3135. <a
href="http://dx.doi.org/10.18632/oncotarget.3060">[More
Information]</a>
Zhou, G., Wilson, G., George, J., Qiao, L. (2015). Targeting
cancer stem cells as a therapeutic approach in liver cancer.
Current Gene Therapy, 15(2), 161-170. <a
href="http://dx.doi.org/10.2174/1566523214666141224095938"
>[More Information]</a>
Charrez, B., Qiao, L., Hebbard, L. (2015). The role of fructose
in metabolism and cancer. Hormone Molecular Biology and
Clinical Investigation, 22(2), 79-89. <a
href="http://dx.doi.org/10.1515/hmbci-2015-0009">[More
Information]</a>
Wu, F., Wang, J., Pu, C., Qiao, L., Jiang, C. (2015). Wilson's
Disease: A Comprehensive Review of the Molecular
Mechanisms. International Journal of Molecular Sciences,
16(3), 6419-6431. <a
href="http://dx.doi.org/10.3390/ijms16036419">[More
Information]</a>
2014
Chen, X., Liu, H., Li, M., Qiao, L. (2014). Advances in non-
surgical management of primary liver cancer. World Journal of
Gastroenterology, 20(44), 16630-16638. <a
href="http://dx.doi.org/10.3748/wjg.v20.i44.16630">[More
Information]</a>
Qiao, L. (2014). Cancer Letters special issue inflammation
andgastrointestinal and liver cancers featuring the guest editor.
Cancer Letters, 345(2), 149-149. <a
href="http://dx.doi.org/10.1016/j.canlet.2013.10.012">[More
Information]</a>
O'Connor, M., Xiang, D., Shigdar, S., Macdonald, J., Li, Y.,
Wang, T., Pu, C., Qiao, L., Duan, W. (2014). Cancer stem cells:
A contentious hypothesis now moving forward. Cancer Letters,
344(2), 180-187. <a
href="http://dx.doi.org/10.1016/j.canlet.2013.11.012">[More
Information]</a>
Zang, S., Liu, T., Shi, J., Qiao, L. (2014). Curcumin: a
promising agent targeting cancer stem cells. Anti-Cancer
Agents in Medicinal Chemistry, 14(6), 787-792. <a
href="http://dx.doi.org/10.2174/1871520614666140521114735"
>[More Information]</a>
Peng, M., Huang, B., Zhang, Q., Fu, S., Wang, D., Cheng, X.,
Wu, X., Xue, Z., Zhang, L., Zhang, D., Qiao, L., et al (2014).
Embelin inhibits pancreatic cancer progression by directly
inducing cancer cell apoptosis and indirectly restricting IL-6
associated inflammatory and immune suppressive cells. Cancer
Letters, 354(2), 407-416. <a
href="http://dx.doi.org/10.1016/j.canlet.2014.08.011">[More
Information]</a>
Dai, Y., Jiao, H., Teng, G., Wang, W., Zhang, R., Wang, Y.,
Hebbard, L., George, J., Qiao, L. (2014). Embelin Reduces
Colitis-Associated Tumorigenesis through Limiting IL-
6/STAT3 Signaling. Molecular Cancer Therapeutics, 13(5),
1206-1216. <a href="http://dx.doi.org/10.1158/1535-
7163.MCT-13-0378">[More Information]</a>
Cao, H., Zhu, K., Fan, J., Qiao, L. (2014). Garlic-Derived Allyl
Sulfides in Cancer Therapy. Anti-Cancer Agents in Medicinal
Chemistry, 14(6), 793-799. <a
href="http://dx.doi.org/10.2174/1871520614666140521120811"
>[More Information]</a>
Wang, F., Meng, W., Wang, B., Qiao, L. (2014). Helicobacter
pylori-induced gastric inflammation and gastric cancer. Cancer
Letters, 345(2), 196-202. <a
href="http://dx.doi.org/10.1016/j.canlet.2013.08.016">[More
Information]</a>
Xu, C., Zhou, W., Wang, Y., Qiao, L. (2014). Hepatitis B virus-
induced hepatocellular carcinoma. Cancer Letters, 345(2), 216-
222. <a
href="http://dx.doi.org/10.1016/j.canlet.2013.08.035">[More
Information]</a>
Duan, X., Qin, P., Yan, S., Ding, W., Fan, J., Qiao, L. (2014).
High-saturate-fat diet delays initiation of diethylnitrosamine-
induced hepatocellular carcinoma. BMC Gastroenterology,
14(1), 1-10. <a href="http://dx.doi.org/10.1186/s12876-014-
0195-9">[More Information]</a>
Lin, J., Shigdar, S., Fang, D., Xiang, D., Wei, M., Danks, A.,
Kong, L., Li, L., Qiao, L., Duan, W. (2014). Improved efficacy
and reduced toxicity of doxorubicin encapsulated in sulfatide-
containing nanoliposome in a glioma model. PloS One, 9(7), 1-
13. <a
href="http://dx.doi.org/10.1371/journal.pone.0103736">[More
Information]</a>
Duan, X., Zhang, L., Fan, J., Qiao, L. (2014). NAFLD leads to
liver cancer: Do we have sufficient evidence? Cancer Letters,
345(2), 230-234. <a
href="http://dx.doi.org/10.1016/j.canlet.2013.07.033">[More
Information]</a>
Zhou, W., Zhang, Q., Qiao, L. (2014). Pathogenesis of liver
cirrhosis. World Journal of Gastroenterology, 20(23), 7312-
7324. <a
href="http://dx.doi.org/10.3748/wjg.v20.i23.7312">[More
Information]</a>
Qiao, L., Li, X. (2014). Role of chronic inflammation in cancers
of the gastrointestinal system and the liver: where we are now.
Cancer Letters, 1168, 207-225. <a
href="http://dx.doi.org/10.1016/j.canlet.2013.10.013">[More
Information]</a>
Dai, Y., Wilson, G., Huang, B., Peng, M., Teng, G., Zhang, D.,
Zhang, R., Ebert, M., Chen, J., Wong, B., George, J., Qiao, L.,
et al (2014). Silencing of Jagged1 inhibits cell growth and
invasion in colorectal cancer. Cell Death and Disease, 5, 1-9.
<a href="http://dx.doi.org/10.1038/cddis.2014.137">[More
Information]</a>
Tian, A., Wilson, G., Lie, S., Wu, G., Hu, Z., Hebbard, L.,
Duan, W., George, J., Qiao, L. (2014). Synergistic effects of
IAP inhibitor LCL161 and paclitaxel on hepatocellular
carcinoma cells. Cancer Letters, 351(2), 232-241. <a
href="http://dx.doi.org/10.1016/j.canlet.2014.06.006">[More
Information]</a>
Peng, M., Xu, S., Zhang, Y., Zhang, L., Huang, B., Fu, S., Xue,
Z., Da, Y., Dai, Y., Qiao, L., et al (2014). Thermosensitive
injectable hydrogel enhances the antitumor effect of embelin in
mouse hepatocellular carcinoma. Journal of Pharmaceutical
Sciences, 103(3), 965-973. <a
href="http://dx.doi.org/10.1002/jps.23885">[More
Information]</a>
2013
Shigdar, S., Macdonald, J., O'Connor, M., Wang, T., Xiang, D.,
Al.Shamaileh, H., Qiao, L., Wei, M., Zhou, S., Zhu, Y., et al
(2013). Aptamers as theranostic agents: Modifications, serum
stability and functionalisation. Sensors, 13(10), 13624-13637.
<a href="http://dx.doi.org/10.3390/s131013624">[More
Information]</a>
Chen, Z., Liu, M., Liu, X., Huang, S., Li, L., Song, B., Li, H.,
Ren, Q., Zenan, H., Zhou, Y., Qiao, L. (2013). COX-2 regulates
E-cadherin expression through the NF-κB/Snail signaling
pathway in gastric cancer. International Journal of Molecular
Medicine, 32(1), 93-100. <a
href="http://dx.doi.org/10.3892/ijmm.2013.1376">[More
Information]</a>
Wilson, G., Hu, Z., Duan, W., Tian, A., Wang, X., McCleod,
D., Lam, V., George, J., Qiao, L. (2013). Efficacy of Using
Cancer Stem Cell Markers in Isolating and Characterising Liver
Cancer Stem Cells. Stem Cells and Development, 22(19), 2655-
2664. <a
href="http://dx.doi.org/10.1089/scd.2012.0703">[More
Information]</a>
Wang, Y., Li, Y., Li, X., Liu, T., Liu, X., Zhang, J., Guo, J.,
Guo, L., Qiao, L. (2013). Hypermethylation of TGF-beta1 gene
promoter in gastric cancer. World Journal of Gastroenterology,
19(33), 5557-5564. <a
href="http://dx.doi.org/10.3748/wjg.v19.i33.5557">[More
Information]</a>
Liu, X., Chen, Z., Li, H., Hu, Z., Liu, M., Tian, A., Zhao, D.,
Wu, J., Zhou, Y., Qiao, L. (2013). Interaction between
cyclooxygenase-2, Snail, and E-cadherin in gastric cancer cells.
World Journal of Gastroenterology, 19(37), 6265-6271. <a
href="http://dx.doi.org/10.3748/wjg.v19.i37.6265">[More
Information]</a>
Hu, Z., Liu, X., Tang, Z., Zhou, Y., Qiao, L. (2013). Possible
regulatory role of Snail in NF-κB-mediated changes in E-
cadherin in gastric cancer. Oncology Reports, 29(3), 993-1000.
<a href="http://dx.doi.org/10.3892/or.2012.2200">[More
Information]</a>
Pu, C., Wang, B., Qiao, L., Pu, C. (2013). Recent progress in
research of biomarkers of acute kidney injury in liver cirrhosis.
Zhonghua Ganzangbing Zazhi (Chinese Journal of
Hepatology), 21(10), 796-798.
Shigdar, S., Qiao, L., Zhou, S., Xiang, D., Wang, T., Li, Y.,
Lim, L., Kong, L., Li, L., Duan, W. (2013). RNA aptamers
targeting cancer stem cell marker CD133. Cancer Letters,
330(1), 84-95. <a
href="http://dx.doi.org/10.1016/j.canlet.2012.11.032">[More
Information]</a>
Wilson, G., Tian, A., Hebbard, L., Duan, W., George, J., Li, X.,
Qiao, L. (2013). Tumoricidal effects of the JAK inhibitor
Ruxolitinib (INC424) on hepatocellular carcinoma in vitro.
Cancer Letters, 341(2), 224-230. <a
href="http://dx.doi.org/10.1016/j.canlet.2013.08.009">[More
Information]</a>
Vongsuvanh, R., George, J., Qiao, L., van der Poorten, D.
(2013). Visceral adiposity in gastrointestinal and hepatic
carcinogenesis. Cancer Letters, 330(1), 1-10. <a
href="http://dx.doi.org/10.1016/j.canlet.2012.11.038">[More
Information]</a>
2012
Tian, A., Qiao, L., Yan, X. (2012). Aging and Hepatocellular
Carcinoma: Possible Molecular Mechanisms. In Liang Qiao,
Yumin Li, Xiang Yan and Jacob George (Eds.), Molecular
Aspects of Hepatocellular Carcinoma, (pp. 80-85). Sharjah:
Bentham Science Publishers. <a
href="http://dx.doi.org/10.2174/978160805072711201010080">
[More Information]</a>
Liu, Q., Zhou, Y., Hu, Z., Qiao, L. (2012). An Overview on
Molecular Therapy for Hepatocellular Carcinoma. In Liang
Qiao, Yumin Li, Xiang Yan and Jacob George (Eds.),
Molecular Aspects of Hepatocellular Carcinoma, (pp. 138-
148). Sharjah: Bentham Science Publishers. <a
href="http://dx.doi.org/10.2174/978160805072711201010138">
[More Information]</a>
Wang, F., Wang, B., Qiao, L. (2012). Association between
obesity and gallbladder cancer. Frontiers in Bioscience, 17,
2550-2558. <a href="http://dx.doi.org/10.2741/4070">[More
Information]</a>
Duan, X., Qiao, L., Fan, J. (2012). Clinical features of
nonalcoholic fatty liver disease-associated hepatocellular
carcinoma. Hepatobiliary & Pancreatic Diseases International,
11(1), 18-27. <a href="http://dx.doi.org/10.1016/S1499-
3872(11)60120-3">[More Information]</a>
Qiao, L., Li, Y., Yan, X., George, J. (2012). Molecular Aspects
of Hepatocellular Carcinoma. Sharjah: Bentham Science
Publishers.
Guo, L., Li, Y., Qiao, L., Liu, T., Du, Y., Zhang, J., He, W.,
Zhao, Y., He, D. (2012). Notch2 regulates matrix
metallopeptidase 9 via PI3K/AKT signaling in human gastric
carcinoma cell MKN-45. World Journal of Gastroenterology,
18(48), 7262-7270. <a
href="http://dx.doi.org/10.3748/wjg.v18.i48.7262">[More
Information]</a>
Li, Q., Zhang, J., Zhou, Y., Qiao, L. (2012). Obesity and gastric
cancer. Frontiers in Bioscience, 17(7), 2383-2390. <a
href="http://dx.doi.org/10.2741/4059">[More Information]</a>
Shen, C., Zhao, C., Zhang, R., Qiao, L. (2012). Obesity-related
hepatocellular carcinoma: roles of risk factors altered in obesity.
Frontiers in Bioscience, 17(6), 2356-2370. <a
href="http://dx.doi.org/10.2741/4057">[More Information]</a>
Li, Z., Chim, J., Yang, M., Ye, J., Wong, B., Qiao, L. (2012).
Role of PCDH10 and its hypermethylation in human gastric
cancer. Biochimica et Biophysica Acta, 1823 (2), 298-305. <a
href="http://dx.doi.org/10.1016/j.bbamcr.2011.11.011">[More
Information]</a>
Jiang, X., Huang, K., Yang, M., Qiao, L., Wang, Q., Ye, J.,
Zhou, H., Yi, Z., Wu, F., Wang, Z., et al (2012). Synergistic
effect of panobinostat and bortezomib on chemoresistant acute
myelogenous leukemia cells via AKT and NF-kB pathways.
Cancer Letters, 326(2), 135-142. <a
href="http://dx.doi.org/10.1016/j.canlet.2012.07.030">[More
Information]</a>
Zhao, C., Liu, X., Shen, C., Wang, Y., Qiao, L. (2012).
Treatment of Hepatocellular Carcinoma with Traditional
Chinese Medicine: Possible Molecular Mechanisms. In Liang
Qiao, Yumin Li, Xiang Yan and Jacob George (Eds.),
Molecular Aspects of Hepatocellular Carcinoma, (pp. 167-
173). Sharjah: Bentham Science Publishers. <a
href="http://dx.doi.org/10.2174/978160805072711201010167">
[More Information]</a>
2011
Li, Z., Chen, J., Chan, K., Qiao, L., Wong, B. (2011). A
possible role of cIAP2 in Helicobacter pylori-associated gastric
cancer. Cancer Letters, 313(2), 192-200. <a
href="http://dx.doi.org/10.1016/j.canlet.2011.09.007">[More
Information]</a>
Liu, S., Wah Chan, K., Tong, J., Wang, Y., Wang, B., Qiao, L.
(2011). PET-CT scan is a valuable modality in the diagnosis of
fibrolamellar hepatocellular carcinoma: a case report and a
summary of recent literature. QJM: Quarterly Journal of
Medicine, 104(6), 477-483. <a
href="http://dx.doi.org/10.1093/qjmed/hcr040">[More
Information]</a>
Wu, J., Lu, H., Ling, X., Wang, C., Rui, J., Wang, A., Qiao, L.
(2011). {2-[(3-Carboxy-1-oxopropyl) amino]-2-deoxy-D-
Glucose} suppresses proliferation and induces apoptosis in the
human esophageal cancer cell line. Medical Oncology: a
leading journal in clinical oncology, 28(4), 986-990. <a
href="http://dx.doi.org/10.1007/s12032-010-9585-1">[More
Information]</a>
2010
Zhou, Y., Li, G., Wu, J., Zhang, Z., Wu, Z., Fan, P., Hao, T.,
Zhang, X., Li, M., Zhang, F., Qiao, L., et al (2010).
Clinicopathological significance of E-cadherin, VEGF, and
MMPs in gastric cancer. Tumor Biology, 31(6), 549-558. <a
href="http://dx.doi.org/10.1007/s13277-010-0068-y">[More
Information]</a>
Ye, J., Chan, G., Qiao, L., Lian, Q., Meng, F., Luo, X.,
Khachigian, L., Ma, M., Deng, R., Chen, J., et al (2010).
Platelet-derived growth factor enhances platelet recovery in a
murine model of radiation-induced thrombocytopenia and
reduces apoptosis in megakaryocytes via its receptors and the
PI3-k/Akt pathway. Haematologica, 95(10), 1745-1753. <a
href="http://dx.doi.org/10.3324/haematol.2009.020958">[More
Information]</a>
2009
Dai, Y., Qiao, L., Chan, K., Yang, M., Ye, J., Zhang, R., Ma, J.,
Zou, B., Lam, C., Wang, J., et al (2009). Adenovirus-mediated
down-regulation of X-linked inhibitor of apoptosis protein
inhibits colon cancer. Molecular Cancer Therapeutics, 8(9),
2762-2770. <a href="http://dx.doi.org/10.1158/1535-
7163.MCT-09-0509">[More Information]</a>
Liu, S., Chan, K., Wang, B., Qiao, L. (2009). Fibrolamellar
Hepatocellular Carcinoma. American Journal of
Gastroenterology, 104(10), 2617-2624. <a
href="http://dx.doi.org/10.1038/ajg.2009.440">[More
Information]</a>
Wang, J., Gu, Q., Li, M., Zhang, W., Yang, M., Zou, B., Chan,
S., Qiao, L., Jiang, B., Tu, S., et al (2009). Identification of
XAF1 as a novel cell cycle regulator through modulating
G(2)/M checkpoint and interaction with checkpoint kinase 1 in
gastrointestinal cancer. Carcinogenesis, 30(9), 1507-1516. <a
href="http://dx.doi.org/10.1093/carcin/bgp155">[More
Information]</a>
Dai, Y., Qiao, L., Chan, K., Yang, M., Ye, J., Ma, J., Zou, B.,
Gu, Q., Wang, J., Lan, H., et al (2009). Peroxisome proliferator-
activated receptor-gamma contributes to the inhibitory effects
of Embelin on colon carcinogenesis. Cancer Research, 69(11),
4776-4783. <a href="http://dx.doi.org/10.1158/0008-5472.CAN-
08-4754">[More Information]</a>
Qiao, L., Wong, B. (2009). Role of Notch signaling in
colorectal cancer. Carcinogenesis, 30(12), 1979-1986. <a
href="http://dx.doi.org/10.1093/carcin/bgp236">[More
Information]</a>
2008
Wu, J., Ren, D., Zhou, Y., Zhang, Z., Zhang, Z., Yan, X.,
Wang, Q., Wang, Z., Wang, H., Zhang, J., et al (2008). A rising
trend of gastric cardia cancer in Gansu Province of China.
Cancer Letters, 269(1), 18-25. <a
href="http://dx.doi.org/10.1016/j.canlet.2008.04.013">[More
Information]</a>
Ma, J., Yang, X., Qiao, L., Liang, L., Chen, M. (2008).
CYP2C9 polymorphism in non-steroidal anti-inflammatory
drugs-induced gastropathy. Journal of Digestive Diseases, 9(2),
79-83. <a href="http://dx.doi.org/10.1111/j.1751-
2980.2008.00326.x">[More Information]</a>
2006
Qiao, L., Zhang, H., Yu, J., Francisco, R., Dent, P., Ebert, M.,
Röcken, C., Farrell, G. (2006). Constitutive activation of NF-
kappaB in human hepatocellular carcinoma: evidence of a
cytoprotective role. Human Gene Therapy, 17(3), 280-290. <a
href="http://dx.doi.org/10.1089/hum.2006.17.280">[More
Information]</a>
Hsu, M., Qiao, L., Ho, V., Zhang, B., Zhang, H., Teoh, N.,
Dent, P., Farrell, G. (2006). Ethanol reduces p38 kinase
activation and cyclin D1 protein expression after partial
hepatectomy in rats. Journal of Hepatology, 44(2), 375-382. <a
href="http://dx.doi.org/10.1016/j.jhep.2005.07.031">[More
Information]</a>
Yu, J., Qiao, L., Zimmermann, L., Ebert, M., Zhang, H., Lin,
W., Röcken, C., Malfertheiner, P., Farrell, G. (2006).
Troglitazone inhibits tumor growth in hepatocellular carcinoma
in vitro and in vivo. Hepatology, 43(1), 134-143. <a
href="http://dx.doi.org/10.1002/hep.20994">[More
Information]</a>
2005
Wu, J., Qi, D., Wei, K., Li, J., Chen, X., Wang, A., liu, W.,
Xue, Q., Qiao, L. (2005). 2-[(3-carboxy-1-oxoprogy1) amino]-2-
deoxy-D-glucose induces apoptosis in Hep G2 cells.
Experimental Oncology, 27(1), 52-55.
Farrell, G., Hou, J., Zhang, H., Francisco, R., Nan, Y., Osvath,
S., Qiao, L., Dela Pena, A., Sedger, L. (2005). Apoptosis occurs
early and involves trail receptors, while hepatocellular
proliferation is delayed but vigorous in a murine dietary model
of steatohepatitis. 56th Annual Meeting of the American
Association for the Study of Liver Diseases, United States: John
Wiley & Sons.
Wu, J., Kou, W., Gao, M., Zubal, G., Wang, A., Xue, Q., Qiao,
L. (2005). Effects of {2-(3-carboxy-1-oxoprogy 1)amino-2-
deoxy-D-glucose} on human hepatocellular carcinoma cell line.
Acta Pharmacologica Sinica, 26(5), 635-640.
Qiao, L., Yu, J., Dent, P., Farrell, G. (2005). NF-kappaB
Protects Rat ARL-6 Hepatocellular Carcinoma Cells Against
Hydrogen Peroxide-Induced Apoptosis. Cancer Biology and
Therapy, 4(11), 1195-1202. <a
href="http://dx.doi.org/10.4161/cbt.4.11.2078">[More
Information]</a>
Liu, Q., Ma, K., He, Z., Dong, J., Hua, X., Huang, X., Qiao, L.
(2005). Radiofrequency ablation for hypersplenism in patients
with liver cirrhosis: A pilot study. Journal of Gastrointestinal
Surgery, 9(5), 648-657. <a
href="http://dx.doi.org/10.1016/j.gassur.2004.11.006">[More
Information]</a>